India Biocon Unit Signs With Ampio Of U.S. To Develop ED Drug
This article was originally published in PharmAsia News
Executive Summary
Syngene, a unit of India's Biocon, has signed an agreement with U.S.-based Ampio Pharmaceuticals to develop its Zertane-ED drug for treating erectile dysfunction.